Organization Name Agios PharmaceuticalsAnnounced Date Apr 26, 2010 Funding Type Series B Funding Stage Early Stage Venture Money Raised
- Celgene
Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Investor Name | Partners |
---|---|
Celgene |
SEC — SEC FORM D